NewYork-Presbyterian Hospital ranks #1 in New York and among the top six in the U.S. out of the nearly 5,000 hospitals evaluated by U.S. News Media & World Report for their 2011-12 Best Hospitals rankings.
Author: The Medical News
Novel bionic eyes for the blind in the making
British scientists have developed the first pair of bionic glasses that could help thousands of legally blind people. These glasses using tiny cameras and software technology from video games, alert the wearer to objects in their surroundings using fla…
New owl study reveals advantage of stereopsis
Using owls as a model, a new research study reveals the advantage of stereopsis, commonly referred to as stereovision, is its ability to discriminate between objects and background; not in perceiving absolute depth.
African-Americans with glaucoma have higher oxygen levels than Caucasians
Measuring oxygen during eye surgery, investigators at Washington University School of Medicine in St. Louis have discovered a reason that may explain why African-Americans have a higher risk of glaucoma than Caucasians.
FDA clears TearScience’s LipiFlow Thermal Pulsation System for evaporative dry eye
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its LipiFlow Thermal Pulsation System for the treatment of meibomian gland dysfunction (MGD), also kn…
AHAF awards 22 new grants to scientists worldwide for innovative vision research
The American Health Assistance Foundation (AHAF), a nonprofit organization with a history of funding cutting-edge research on age-related diseases, announced today that it has awarded 22 new grants totaling nearly $2.2 million to scientists worldwide w…
Healthy diet might help reduce risk of macular degeneration
Eating a diet high in vitamin D, as well as the nutrients betaine and methionine, might help reduce the risk of macular degeneration, according to new research conducted by Tufts Medical Center scientists. Their study of identical twins from the US Wor…
Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases
Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.
Positive results from RISE and RIDE Phase III trials of Genentech’s Lucentis for diabetic macular edema
Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML
Over a decade ago, Canadian patients diagnosed with chronic myeloid leukemia (CML), celebrated when PrGleevec (imatinib mesylate) was approved in Canada.
STAAR Surgical completes first procedures to implant Visian ICL V4c design
STAAR Surgical Company, the leading developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced the completion of the first procedures to implant its recently CE Mark-approved Visian Implantable …
Growth-braking tumor-suppressor gene slows growth of childhood brain tumors
Johns Hopkins researchers have found a likely explanation for the slow growth of the most common childhood brain tumor, pilocytic astrocytoma. Using tests on a new cell-based model of the tumor, they concluded that the initial process of tumor formatio…
Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years
Allergan, Inc. today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan’s LAP-BAND Adjustable Gastric Banding Sy…
Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease
Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that ca…
Children’s Medical Center to open new $21M Specialty Care Center in Southlake
Children’s Medical Center will debut its new Specialty Care Center in Southlake on June 18, a $21 million expansion which will serve children in one of the state’s fastest-growing cities and the surrounding communities.
InNexus files patent protection for new Age-related Macular Degeneration therapeutic
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody produ…
Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID
New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero induces a robust immune response to meningococcal serogroup B when given alone or when co-administered with other routine vaccines.
OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada
OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France, …
DATATRAK adds Research Dynamics to Connect Partner Program
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the addition of Research Dynamics Consulting Group LTD to its Connect Partner Program.